Review on asymmetric synthetic methodologies for chiral isoquinuclidines; 2008 to date

• DOI: 10.1016/j.tetasy.2017.10.013
• Publication Date: 2017-11-11T06:31:57Z
• Authors: Muhammad Faisal; Danish Shahzad; Aamer Saeed; Bhajan Lal; Shomaila Saeed; Fayaz Ali Larik; Pervaiz Ali Channar; Parvez Ali Mahesar; Jamaluddin Mahar
• Keywords: 01 natural sciences; 0104 chemical sciences; 3. Good health

Abstract Isoquinuclidines constitute the central structural nucleus of numerous biologically active natural products, for example, iboga alkaloids such as ibogamine and catharanthine as well as non-indole-containing alkaloids such as the dioscorine and the cannivonines. Furthermore, in medicinal and pharmaceutical chemistry, the isoquinuclidine core is commonly employed as a rigid azabicyclic scaffold, thus providing significant precursors in the synthesis of numerous valuable alkaloids. Summarizing well-organized approaches to access the chiral isoquinuclidine structural centerpiece signifies a significant endeavor not only for developing biologically active natural products but also enhancing biological researches that can lead to possible drug discovery. Over time, the values and methodologies for the asymmetric synthesis of chiral isoquinuclidines are increasing; hence to advance asymmetric synthesis, this review combines and discusses the pros and cons of each synthesis techniques from 2008. This review should be helpful for promoting further developments of asymmetric synthetic methodologies and for medicinal chemistry.